SHMT2 and cancer: We thought that although SHMT2‐WT underwent dynamic processes of phosphorylation and dephosphorylation in cancer cells, the phosphorylation state may be dominant because of the constitutive activation of MAPK1 pathway in cancer cells and the dephosphorylated SHMT2 could be rapidly rephosphorylated on Ser90.